26Jul 2023
Long‐term treatment outcomes in refractory rhinitis medicamentosa managed with nasal surgery

Long‐term treatment outcomes in refractory rhinitis medicamentosa managed with nasal surgery

A study revealed nasal surgery's long-term benefits for refractory Rhinitis Medicamentosa (RM), a condition with limited treatment options. Patients who underwent surgery achieved a 91.1% total cessation of decongestants and significant symptom improvement. The study followed 56 patients for an average of 3.4 years. Ongoing users of decongestants were more likely to have concomitant asthma, reduced symptom improvement, and continued use of nasal corticosteroids and saline sprays.

  • #ent

Like

Save

Share